M. Bellin, M. Lowe, M. Bridget Zimmerman, M. Wilschanski, S. Werlin, David M. Troendle, U. Shah, S. Schwarzenberg, John Pohl, E. Perito, Chee Y. Ooi, J. Nathan, V. Morinville, Brian McFerron, Maria Mascarenhas, A. Maqbool, Quin Liu, T. Lin, S. Husain, R. Himes, Melvin B. Heyman, T. Gonska, Matthew J. Giefer, C. Gariepy, Steven D. Freedman, D. Fishman, B. Barth, M. Abu-El-Haija, A. Uc
{"title":"急性复发性和慢性胰腺炎患儿的糖尿病:来自inspire队列的数据。","authors":"M. Bellin, M. Lowe, M. Bridget Zimmerman, M. Wilschanski, S. Werlin, David M. Troendle, U. Shah, S. Schwarzenberg, John Pohl, E. Perito, Chee Y. Ooi, J. Nathan, V. Morinville, Brian McFerron, Maria Mascarenhas, A. Maqbool, Quin Liu, T. Lin, S. Husain, R. Himes, Melvin B. Heyman, T. Gonska, Matthew J. Giefer, C. Gariepy, Steven D. Freedman, D. Fishman, B. Barth, M. Abu-El-Haija, A. Uc","doi":"10.1097/MPG.0000000000002482","DOIUrl":null,"url":null,"abstract":"OBJECTIVES\nAdults with chronic pancreatitis (CP) have a high risk for developing pancreatogenic diabetes mellitus (DM), but little is known regarding potential risk factors for DM in children with acute recurrent pancreatitis (ARP) or CP. We compared demographic and clinical features of children with ARP or CP, with and without DM, in the INternational Study Group of Pediatric Pancreatitis: In Search of a CuRE (INSPPIRE) registry.\n\n\nMETHODS\nWe reviewed the INSPPIRE database for the presence or absence of physician-diagnosed DM in 397 children, excluding those with total pancreatectomy with islet autotransplantation, enrolled from August 2012 to August 2017. Patient demographics, body mass index percentile, age at disease onset, disease risk factors, disease burden, and treatments were compared between children with DM (n = 24) and without DM (n = 373).\n\n\nRESULTS\n24 children (6.0% of the cohort) had a diagnosis of DM. Five of 13 tested were positive for beta cell autoantibodies. The DM group was 4.2 years (95% CI 3.0, 5.4) older at first episode of acute pancreatitis, and tended to more often have hypertriglyceridemia (odds ratio (OR) 5.21 (1.33, 17.05)), coexisting autoimmune disease (OR 3.94 (0.88, 13.65)) or pancreatic atrophy (OR 3.64 (1.13, 11.59)).\n\n\nCONCLUSIONS\nPancreatic atrophy may be more common among children with DM, suggesting more advanced exocrine disease. However, data in this exploratory cohort also suggest increased autoimmunity and hypertriglyceridemia in children with DM, suggesting that risk factors for Type 1 and Type 2 DM respectively may play a role in mediating DM development in children with pancreatitis.","PeriodicalId":16725,"journal":{"name":"Journal of Pediatric Gastroenterology & Nutrition","volume":"87 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"15","resultStr":"{\"title\":\"Diabetes Mellitus in Children with Acute Recurrent and Chronic Pancreatitis: Data from the INSPPIRE Cohort.\",\"authors\":\"M. Bellin, M. Lowe, M. Bridget Zimmerman, M. Wilschanski, S. Werlin, David M. Troendle, U. Shah, S. Schwarzenberg, John Pohl, E. Perito, Chee Y. Ooi, J. Nathan, V. Morinville, Brian McFerron, Maria Mascarenhas, A. Maqbool, Quin Liu, T. Lin, S. Husain, R. Himes, Melvin B. Heyman, T. Gonska, Matthew J. Giefer, C. Gariepy, Steven D. Freedman, D. Fishman, B. Barth, M. Abu-El-Haija, A. Uc\",\"doi\":\"10.1097/MPG.0000000000002482\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"OBJECTIVES\\nAdults with chronic pancreatitis (CP) have a high risk for developing pancreatogenic diabetes mellitus (DM), but little is known regarding potential risk factors for DM in children with acute recurrent pancreatitis (ARP) or CP. We compared demographic and clinical features of children with ARP or CP, with and without DM, in the INternational Study Group of Pediatric Pancreatitis: In Search of a CuRE (INSPPIRE) registry.\\n\\n\\nMETHODS\\nWe reviewed the INSPPIRE database for the presence or absence of physician-diagnosed DM in 397 children, excluding those with total pancreatectomy with islet autotransplantation, enrolled from August 2012 to August 2017. Patient demographics, body mass index percentile, age at disease onset, disease risk factors, disease burden, and treatments were compared between children with DM (n = 24) and without DM (n = 373).\\n\\n\\nRESULTS\\n24 children (6.0% of the cohort) had a diagnosis of DM. Five of 13 tested were positive for beta cell autoantibodies. The DM group was 4.2 years (95% CI 3.0, 5.4) older at first episode of acute pancreatitis, and tended to more often have hypertriglyceridemia (odds ratio (OR) 5.21 (1.33, 17.05)), coexisting autoimmune disease (OR 3.94 (0.88, 13.65)) or pancreatic atrophy (OR 3.64 (1.13, 11.59)).\\n\\n\\nCONCLUSIONS\\nPancreatic atrophy may be more common among children with DM, suggesting more advanced exocrine disease. However, data in this exploratory cohort also suggest increased autoimmunity and hypertriglyceridemia in children with DM, suggesting that risk factors for Type 1 and Type 2 DM respectively may play a role in mediating DM development in children with pancreatitis.\",\"PeriodicalId\":16725,\"journal\":{\"name\":\"Journal of Pediatric Gastroenterology & Nutrition\",\"volume\":\"87 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"15\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pediatric Gastroenterology & Nutrition\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/MPG.0000000000002482\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pediatric Gastroenterology & Nutrition","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/MPG.0000000000002482","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Diabetes Mellitus in Children with Acute Recurrent and Chronic Pancreatitis: Data from the INSPPIRE Cohort.
OBJECTIVES
Adults with chronic pancreatitis (CP) have a high risk for developing pancreatogenic diabetes mellitus (DM), but little is known regarding potential risk factors for DM in children with acute recurrent pancreatitis (ARP) or CP. We compared demographic and clinical features of children with ARP or CP, with and without DM, in the INternational Study Group of Pediatric Pancreatitis: In Search of a CuRE (INSPPIRE) registry.
METHODS
We reviewed the INSPPIRE database for the presence or absence of physician-diagnosed DM in 397 children, excluding those with total pancreatectomy with islet autotransplantation, enrolled from August 2012 to August 2017. Patient demographics, body mass index percentile, age at disease onset, disease risk factors, disease burden, and treatments were compared between children with DM (n = 24) and without DM (n = 373).
RESULTS
24 children (6.0% of the cohort) had a diagnosis of DM. Five of 13 tested were positive for beta cell autoantibodies. The DM group was 4.2 years (95% CI 3.0, 5.4) older at first episode of acute pancreatitis, and tended to more often have hypertriglyceridemia (odds ratio (OR) 5.21 (1.33, 17.05)), coexisting autoimmune disease (OR 3.94 (0.88, 13.65)) or pancreatic atrophy (OR 3.64 (1.13, 11.59)).
CONCLUSIONS
Pancreatic atrophy may be more common among children with DM, suggesting more advanced exocrine disease. However, data in this exploratory cohort also suggest increased autoimmunity and hypertriglyceridemia in children with DM, suggesting that risk factors for Type 1 and Type 2 DM respectively may play a role in mediating DM development in children with pancreatitis.